IP Library Granted Patent US 9,128,038
Granted Patent B2
US 9,128,038 · App. 13/529,901 · Granted Sep 8, 2015

Analytical test strip with capillary sample-receiving chambers separated by a physical barrier island

Inventors: Lynsey Whyte (Inverness, GB); Scott Sloss (Inverness, GB); David Mccoll (Inverness, GB); Neil Whitehead (Inverness, GB); Antony Smith (Inverness, GB)
Assignee: LifeScan Scotland Limited
G01N27/3272G01N27/3274G01N33/492B01L3/502B01L2300/0825
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,128,038
App. No.
13/529,901
Granted
Sep 8, 2015
Kind
B2
Abstract

An analytical test strip for the determination of an analyte (such as glucose and/or hematocrit) in a bodily fluid sample (such as a whole blood sample) includes a first capillary sample-receiving chamber, a second capillary sample-receiving chamber, and a physical barrier island disposed between the first and second capillary sample-receiving chambers. Moreover, the physical island barrier is disposed such that bodily fluid sample flow between the first capillary sample-receiving chamber and the second capillary sample-receiving chamber is prevented during use of the analytical test strip.

Claims (21)

1. An analytical test strip for the determination of an analyte in a bodily fluid sample, the analytical test strip comprising:

an electrically insulating substrate layer;

at least one reference electrode and a plurality of working electrodes, all of which are disposed on the electrically insulating substrate layer;

an enzymatic reagent layer disposed over at least one of, but not all of the working electrodes;

a first capillary sample-receiving chamber;

a second capillary sample-receiving chamber;

a physical barrier island disposed between the first capillary sample-receiving chamber and the second capillary receiving chamber, and

wherein the physical island barrier is disposed such that bodily fluid sample flow between the first capillary sample-receiving chamber and the second capillary sample-receiving chamber during use of the analytical test strip is prevented.

2. The analytical test strip of claim 1 wherein the first capillary sample receiving chamber has at least one sample application opening and the second sample receiving chamber has at least one sample application opening, and

wherein the sample application opening of the first capillary sample-receiving chamber and the sample application opening of the second sample-receiving chamber are juxtaposed such that a single bodily fluid sample can be simultaneously applied thereto.

3. The analytical test strip of claim 1 wherein the first capillary sample-receiving chamber has a first sample application opening and a second sample application opening and wherein the second sample-receiving chamber has a first sample application opening and a second sample application opening.

4. The analytical test strip of claim 3 wherein the physical barrier island extends longitudinally along the first capillary sample-receiving chamber and the second capillary sample-receiving chamber.

5. The analytical test strip of claim 4 wherein the physical barrier island is disposed such that:

a first shared sample entry chamber is defined at the first sample application opening of the first capillary sample-receiving chamber and the first sample application opening of the second capillary-sample receiving chamber, and

a second shared sample entry chamber is defined at the second sample application opening of the first capillary sample-receiving chamber and the second sample application opening of the second capillary sample-receiving chamber.

6. The analytical test strip of claim 5 wherein a width of the first shared sample entry chamber is greater than the sum of widths of the first sample application opening of the first capillary sample-receiving chamber and the first sample application opening of the second capillary-sample receiving chamber, and

wherein a width of the second shared sample entry chamber is greater than the sum of widths of the second sample application opening of the first capillary sample-receiving chamber and the second sample application opening of the second capillary-sample receiving chamber.

7. The analytical test strip of claim 1 wherein the analytical test strip is configured as an electrochemical-based analytical test strip.

8. The analytical test strip of claim 1 wherein the bodily fluid sample is a whole blood sample.

9. The analytical test strip of claim 1 wherein the analyte is glucose.

10. The analytical test strip of claim 1 wherein the analyte is glucose and the analytical test strip is configured to determine the analyte in a bodily fluid sample introduced to the first capillary sample-receiving chamber and hematocrit of a bodily fluid sample introduced into the second capillary sample-receiving chamber.

Assignments (11)
RELEASE OF SECURITY INTEREST Recorded Dec 8, 2025
From: WILMINGTON SAVINGS FUND SOCIETY, FSB
To: LIFESCAN IP HOLDINGS, LLC
Reel/Frame 073929/0316 →
RELEASE OF SECURITY INTEREST Recorded Dec 8, 2025
From: WILMINGTON SAVINGS FUND SOCIETY, FSBWILMINGTON SAVINGS FUND SOCIETY, FSB
To: LIFESCAN IP HOLDINGS, LLC
Reel/Frame 073928/0626 →
RELEASE OF SECOND LIEN PATENT SECURITY AGREEMENT RECORDED OCT. 3, 2018, REEL/FRAME 047186/0836 Recorded Jun 28, 2023
From: BANK OF AMERICA, N.A.
To: LIFESCAN IP HOLDINGS, LLC; JANSSEN BIOTECH, INC.; JOHNSON & JOHNSON CONSUMER INC.
Reel/Frame 064206/0176 →
SECOND LIEN PATENT SECURITY AGREEMENT Recorded May 23, 2023
From: LIFESCAN IP HOLDINGS, LLC
To: BANK OF AMERICA, N.A.
Reel/Frame 063740/0080 →
FIRST LIEN PATENT SECURITY AGREEMENT Recorded May 22, 2023
From: LIFESCAN IP HOLDINGS, LLC
To: BANK OF AMERICA, N.A.
Reel/Frame 063712/0430 →
CORRECTIVE ASSIGNMENT TO CORRECT THE DELETING PROPERTY NUMBER 6990849, 7169116, 7351770, 7462265,7468125, 7572356, 8093903, 8486245, 8066866 AND ADD 10431140 PREVIOUSLY RECORDED AT REEL: 050839 FRAME: 0634. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded May 12, 2023
From: LIFESCAN SCOTLAND LTD.
To: CILAG GMBH INTERNATIONAL
Reel/Frame 064656/0141 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2019
From: CILAG GMBH INTERNATIONAL
To: LIFESCAN IP HOLDINGS, LLC
Reel/Frame 050840/0006 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2019
From: LIFESCAN SCOTLAND LTD.
To: CILAG GMBH INTERNATIONAL
Reel/Frame 050839/0634 →
SECURITY AGREEMENT Recorded Oct 3, 2018
From: LIFESCAN IP HOLDINGS, LLC
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 047186/0836 →
SECURITY AGREEMENT Recorded Oct 2, 2018
From: LIFESCAN IP HOLDINGS, LLC
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 047179/0150 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 26, 2012
From: WHYTE, LYNSEY; SLOSS, SCOTT; MCCOLL, DAVID; WHITEHEAD, NEIL; SMITH, ANTONY
To: LIFESCAN SCOTLAND LIMITED
Reel/Frame 028445/0289 →
Continuity (1)
Related Publication 20130341209A1 · Dec 26, 2013